Procurement Summary
Country: Poland
Summary: Successive Delivery of Biological Drugs Covered by the National Health Fund Drug Program
Deadline: 16 Apr 2026
Posting Date: 17 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 137982123
Document Ref. No.: 183285-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
33631300 - Antipsoriatics
33690000 - Various medicinal products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The subject of the order is the successive delivery of biological drugs covered by the National Health Fund drug program for 105 Kresowy SzWzP SPZOZ in Żary, divided into 10 parts Delivery of the biologic drug Ixekizumab included in the moderate drug program and severe plaque psoriasis in adults The subject of the order is the supply of the biological drug Ixekizumab covered by the drug program, covered by part No. 1 - a detailed description of the subject of the order is included in Annex No. 8 a) to the SWZ - an assortment and price form in accordance with the principles specified in the contract template constituting Annex No. 9 a) to the SWZ Delivery of the biological drug Adalimumab included in the drug program for the treatment of moderate and severe plaque psoriasis in people adults who qualify for general treatment. The subject of the order is the supply of the biological drug Adalimumab covered by the drug program, covered by part No. 2 - a detailed description of the subject of the order is included in Annex No. 8 b) to the SWZ - assortment and price form in accordance with the principles specified in the contract template constituting Annex No. 9 a) to the SWZ Delivery of the biological drug Ustekinumabum included in the drug program for the treatment of moderate and severe plaque psoriasis in people adults who qualify for general treatment. The subject of the order is the supply of the biological drug Ustekinumabum covered by the drug program, covered by part no. 3 - detailed description of...
Document Type: Contract Notice Reference Number: 105.KSzWzPSPZOZ-DZP-2612-10/UE/2026/WG Contract Type: supplies Authority Type: body-pl Doc Title: Successful delivery of biological drugs covered by the National Health Fund drug program Dispatch Date: 2026-03-16 Publish Date: 2026-03-17 Submission Date: 2026-04-16
Documents
Tender Notice